SLF vs UNH vs CVS vs MFC vs ELV

For growth investors, Manulife Financial Corporation (MFC) is the stronger pick with 937.

7% revenue growth year-over-year, versus 7. 8% for CVS Health Corporation (CVS). Elevance Health Inc. (ELV) offers the better valuation at 14. 8x trailing P/E (13. 9x forward), making it the more compelling value choice. Analysts rate UnitedHealth Group Incorporated (UNH) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Elevance Health Inc.

(ELV) is the cheapest at 14. 8x versus CVS Health Corporation at 62. 8x. On forward P/E, Manulife Financial Corporation is actually cheaper at 8. 5x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Sun Life Financial Inc. wins at 1. 40x versus Manulife Financial Corporation's 9. 06x — a reasonable growth-adjusted valuation.

Over the past 5 years, Manulife Financial Corporation (MFC) delivered a total return of +112.

1%, compared to -2. 6% for UnitedHealth Group Incorporated (UNH). Over 10 years, the gap is even starker: MFC returned +247. 7% versus CVS's +3. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), CVS Health Corporation (CVS) is the lower-risk stock at 0.

05β versus Manulife Financial Corporation's 0. 99β — meaning MFC is approximately 1851% more volatile than CVS relative to the S&P 500. On balance sheet safety, Manulife Financial Corporation (MFC) carries a lower debt/equity ratio of 28% versus 124% for CVS Health Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Manulife Financial Corporation (MFC) is pulling ahead at 937.

7% versus 7. 8% for CVS Health Corporation (CVS). On earnings-per-share growth, the picture is similar: Sun Life Financial Inc. grew EPS 16. 7% year-over-year, compared to -62. 0% for CVS Health Corporation. Over a 3-year CAGR, SLF leads at 130. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Manulife Financial Corporation (MFC) is the more profitable company, earning 9.

5% net margin versus 0. 4% for CVS Health Corporation — meaning it keeps 9. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MFC leads at 11. 6% versus 2. 6% for CVS. At the gross margin level — before operating expenses — SLF leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Sun Life Financial Inc. (SLF) is the more undervalued stock at a PEG of 1. 40x versus Manulife Financial Corporation's 9. 06x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Manulife Financial Corporation (MFC) trades at 8. 5x forward P/E versus 20. 2x for UnitedHealth Group Incorporated — 11. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MFC: 28. 9% to $51. 00.

All stocks in this comparison pay dividends.

Manulife Financial Corporation (MFC) offers the highest yield at 4. 9%, versus 1. 8% for Elevance Health Inc. (ELV).

For long-horizon retirement investors, CVS Health Corporation (CVS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

05), 3. 1% yield). Both have compounded well over 10 years (CVS: +3. 5%, MFC: +247. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (SLF (Financial Services) and UNH (Healthcare) and CVS (Healthcare) and MFC (Financial Services) and ELV (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SLF is a mid-cap high-growth stock; UNH is a large-cap quality compounder stock; CVS is a mid-cap income-oriented stock; MFC is a mid-cap high-growth stock; ELV is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.